spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

Safe’n’Spray™, the smart electronic concept device with child-resistant and locking features, wins the ‘Best Innovation In Drug Delivery Device’ Award at Pharmapack 2020

Nemera

A team of industry experts awarded Nemera’s Safe’n’Spray with a prestigious Pharmapack Award for ‘Best Innovation in Drug Delivery Device’.

On February 5th, during the Pharmapack Awards Ceremony, Safe’n’Spray, Nemera’s smart electronic concept device with child-resistant and locking features, was celebrated as the “Best Innovation in Drug Delivery Device”.

Safe’n’Spray is an integrated device with reusable electronic locking unit and fingerprint identification, to monitor drug delivered and prevent patient from overdosing. Safe'n'Spray responds to specific needs of controlling the doses delivered to patients in a defined period of time, in order to prevent any overdosing.

Indeed, Safe'n'Spray offers maximum safety for patients while using multidose potent drug products, without any risk of overdosing compared to other systems (e.g. unit-dose).

Moreover, Safe'n'Spray offers a unique possibility to reuse the "SAFE" electronic part once the "SPRAY" part with the drug is over (eco-friendly on both economic and ecologic sides).


The fingerprint sensor for patient unique identification acts as an easy and intuitive child-resistant feature, without the need for adding any secondary packaging with a Child resistant function.

Opposite to fully integrated devices, Safe'n'Spray does not change the manufacturing process of primary packaging on existing filling lines, as another module will deal with assembling Safe'n'Spray around primary packaging.

Last but not least, Safe'n'Spray is a connected device, linked with e-Nemera Cloud Solution, Nemera’s cloud platform. It offers access to patients, healthcare professionals and pharma companies for various services: treatment management, statistical analysis, etc.

“We are very proud to receive this prestigious award.” – said Marc Hämel, Nemera’s CEO – “According to the World Health Organization, overdose deaths contribute to between roughly a third and a half of all drug-related deaths, which are attributable in most cases to opioids. With Safe’n’SprayTM, we offer a solution to prevent any overdosing thanks to the different electronic features. This product is also user-friendly, child-resistant and sustainable, with a reusable electronic locking unit. Receiving the Pharmapack ‘Best Innovation in Drug Delivery Device’ Award is a great recognition for all our teams working every day to improve patients’ lives with innovative ideas.”



Launched in 1997, the Pharmapack Awards celebrate the latest innovations from packaging companies within the drugs, medical devices, health products and veterinary drugs sectors.

Safe’n’Spray at a glance:

Benefits for patients:
- Prevent overdosing of potent drugs (e.g. breakthrough pain)
- Intuitive and easy to use (fingerprint identification & simple display)

KEY DIFFERENTIATORS
- Reusable electronic locking unit for cost-savings
- Fingerprint for patient ID and as a smart child resistant function
- Simple display (doses left, remaining time for the next dose, feedback in case of misuse) 
- Relevant data available through e-Nemera cloud system

You can learn more about Safe’n’Spray at https://www.nemera.net/products/ear-nasal-throat/safenspray/
phone +33 4 74 94 06 54
email information@nemera.net
web www.nemera.net
email 20 avenue de la Gare, 38290 – La Verpillière, France
 
Print this page
Send to a friend
   
spacer
News and Press Releases

High Throughput Analytics Herald a Paradigm Shift in the Development of Biopharmaceuticals

Heilbronn/Dortmund August 2019: Biopharmaceuticals have revolutionized therapies of various diseases. In particular with regard to chronical and/or severe clinical conditions like multiple sclerosis, rheumatoid arthritis or cancer they are considered the future of treatment. Also economically biological drugs are on their way up: The global biopharmaceuticals market is anticipated to reach about 400 billion USD by 2025. Which strategic alignment will help best to fill a successful pipeline?
More info >>


White Papers

The Process of Informed Consent (written by ACRP)

CenterWatch

Every investigator and clinical research coordinator (CRC) should recognize the importance of obtaining valid and appropriate informed consent as an important protection of the rights and welfare of human subjects. The purpose of this ACRP guidance document is not to provide a literature review or summarize the recommendations of various working groups. Instead, the Association decided it would be helpful to provide short and focused guidance which describes how to best structure the informed consent process in accordance with best practices.
More info >>

Industry Events

Evolution Summit

2-4 March 2020, The Meritage Resort & Spa, Napa, CA, USA

The 21st Evolution Summit is an invitation-only, premium Summit bringing leading clinical trial executives and innovative suppliers & solution providers together. The Summit’s content is aligned with key clinical trial challenges and interests, relevant market developments, and practical and progressive ideas and strategies adopted by successful pioneers.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement